NCT02200952View on ClinicalTrials.gov

Luteal Phase Supplementation With Recombinant LH After GnRh Agonist Oocytes Triggering in Women at Risk of OHSS

CompletedOBSERVATIONAL
Enrollment

16

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Ovarian Hyperstimulation Syndrome
Interventions
DRUG

recombinant LH

recombinant LH twice/day for 10 days from pick up

Trial Locations (1)

85100

San carlo Public Hospital, Potenza

All Listed Sponsors
lead

San Carlo Public Hospital, Potenza, Italy

OTHER

NCT02200952 - Luteal Phase Supplementation With Recombinant LH After GnRh Agonist Oocytes Triggering in Women at Risk of OHSS | Biotech Hunter | Biotech Hunter